Security record · archived quarter
IDYA
IDEAYA Biosciences, Inc. · Healthcare · Biotechnology
13Tracked holders
—Δ holders
11.98MShares held
$420.72MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | +4 | 68.09M | $2.53B | +10 | −5 |
| Q1 2026 | 98 | +2 | 72.39M | $2.41B | +9 | −8 |
| Q4 2025 | 96 | 0 | 74.31M | $2.57B | +1 | — |
| Q3 2025 | 17 | -1 | 45.06M | $1.23B | — | −2 |
| Q2 2025 | 16 | 0 | 43.75M | $919.60M | +1 | −1 |
| Q1 2025 | 13 | -1 | 14.55M | $238.33M | +1 | −2 |
| Q4 2024 | 14 | +1 | 14.99M | $385.22M | +1 | — |
| Q3 2024 | 12 | -1 | 10.73M | $339.97M | — | −1 |
| Q2 2024 | 13 | — | 11.98M | $420.72M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 3.74M | — | $131.44M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.74M | — | $131.44M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Adage Capital Partners ✦ | 2.07M | — | $72.51M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.77M | — | $62.25M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.77M | — | $62.25M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.48M | — | $51.94M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.48M | — | $51.94M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 884.54K | — | $31.06M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 884.54K | — | $31.06M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Fisher Asset Management ✦ | 669.79K | — | $23.52M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 604.55K | — | $21.23M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 258.61K | — | $9.08M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 188.01K | — | $6.60M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 188.01K | — | $6.60M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 109.33K | — | $3.84M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 98.81K | — | $3.47M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Norges Bank ✦ (passive) | 92.60K | — | $3.25M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 15.63K | — | $548,839 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 15.63K | — | $548,839 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 253 holders, 94.40M shares, $3.10B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API